TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - PFIZER INC Share Price

Certificat

DE000CL344L3

Market Closed - Deutsche Boerse AG 20:51:30 15/05/2024 BST
0.44 EUR +10.00% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - PFIZER INC
Current month+214.29%
1 month+158.82%
Date Price Change
15/05/24 0.44 +10.00%
14/05/24 0.4 0.00%
13/05/24 0.4 +8.11%
10/05/24 0.37 -2.63%
09/05/24 0.38 0.00%

Delayed Quote Deutsche Boerse AG

Last update May 15, 2024 at 08:51 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN CL344L
ISINDE000CL344L3
Date issued 03/03/2020
Strike 24.08 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.95
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 3.53
Lowest since issue 0.11

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.82 USD
Average target price
31.94 USD
Spread / Average Target
+10.82%
Consensus